• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Wien Med Wochenschr . Chest CT severity score: assessment of COVID‑19 severity and short-term prognosis in hospitalized Iranian patients

tetano

Editor, Senior Moderator
Wien Med Wochenschr


. 2022 Feb 8;1-7.
doi: 10.1007/s10354-022-00914-5. Online ahead of print.
Chest CT severity score: assessment of COVID‑19 severity and short-term prognosis in hospitalized Iranian patients


Alireza Aziz-Ahari[SUP] 1 [/SUP], Mahsa Keyhanian[SUP] 1 [/SUP], Setareh Mamishi[SUP] 2 3 [/SUP], Shima Mahmoudi[SUP] 2 3 [/SUP], Ebrahim Ebrahimi Bastani[SUP] 1 [/SUP], Fatemeh Asadi[SUP] 4 [/SUP], Mohammadreza Khaleghi[SUP] 5 6 [/SUP]



Affiliations

Abstract

Background: The aim of this study was to evaluate the value of chest computed tomography (CT) severity score in the assessment of coronavirus disease 2019 (COVID‑19) severity and short-term prognosis.
Methods: In this cross-sectional study, we evaluated all patients who were referred to our university hospital, from 21 May 2020 to 22 June 2020 with positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reverse transcription-polymerase chain reaction (RT-PCR) test. The patients suspected of having other respiratory diseases including influenza, according to an infectious disease specialist, and those without chest CT scan were excluded. A chest CT was obtained for all patients between days 4 and 7 days after symptom onset. Chest CT severity score was also calculated based on the degree of involvement of the lung lobes as 0%, (0 points), 1-25% (1 point), 26-50% (2 points), 51-75% (3 points), and 76-100% (4 points). The CT severity score was quantified by summing the 5 lobe indices (range 0-20). The ROC curve analysis was performed for the clinical value of CT scores in distinguishing the patients based on the severity of disease (mild/moderate group versus severe group), ICU admission, intubation requirement, and mortality.
Results: Of the 148 patients included, 93 patients recovered, while 55 patients died (mortality rate 37%). The area under the curve of CT score for discriminating of recovered patients from deceased individuals was 0.726, and the optimal CT score threshold was 15.5 with 61.8% sensitivity and 76.3% specificity. The best CT score cut-off for discriminating of patients based on the severity of disease was 12.5 with 68.3% sensitivity and 72.7% specificity. In addition, with CT score cut-off of 15.5, sensitivities of 70.8% and 51.6% and specificities of 78% and 72.6% were observed for intubation and ICU admission, respectively.
Conclusion: CT scan and semiquantitative scoring method could be beneficial and applicable in predicting the patient's condition.

Keywords: Computed tomography scan; Computed tomography severity score; Coronavirus disease 2019; Mortality; Severity.
 
Back
Top Bottom